Gain an overview of sepiapterin’s distinct dual mechanism of action in phenylketonuria (PKU), highlighting how it increases phenylalanine hydroxylase (PAH) function and improves conversion of phenylalanine (Phe) to tyrosine (Tyr).
All resources
Access additional materials on phenylketonuria (PKU), including practical tools and educational content, below.
|
Topic
Type
Year
Always consult the prescribing information before prescribing any products
MED-US-CORP-2500008 | November 2025
MED-US-PKU-2600087 | June 2026